NDC 0067-2001

Excedrin Extra Strength Pain Reliever

Acetaminophen, Aspirin (nsaid), And Caffeine

Excedrin Extra Strength Pain Reliever is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Acetaminophen; Aspirin; Caffeine.

Product ID0067-2001_1b5ff867-5442-4cf8-bd1e-530093cc88f8
NDC0067-2001
Product TypeHuman Otc Drug
Proprietary NameExcedrin Extra Strength Pain Reliever
Generic NameAcetaminophen, Aspirin (nsaid), And Caffeine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2019-03-15
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart343
Labeler NameGlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Substance NameACETAMINOPHEN; ASPIRIN; CAFFEINE
Active Ingredient Strength250 mg/1; mg/1; mg/1
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0067-2001-01

2 TABLET, FILM COATED in 1 POUCH (0067-2001-01)
Marketing Start Date2021-01-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0067-2001-05 [00067200105]

Excedrin Extra Strength Pain Reliever TABLET, FILM COATED
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-03-15

NDC 0067-2001-08 [00067200108]

Excedrin Extra Strength Pain Reliever TABLET, FILM COATED
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-03-15

Drug Details

Active Ingredients

IngredientStrength
ACETAMINOPHEN250 mg/1

OpenFDA Data

SPL SET ID:1b5ff867-5442-4cf8-bd1e-530093cc88f8
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 308297
  • 209468
  • Pharm Class PE
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
  • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
  • NUI Code
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722
  • NDC Crossover Matching brand name "Excedrin Extra Strength Pain Reliever" or generic name "Acetaminophen, Aspirin (nsaid), And Caffeine"

    NDCBrand NameGeneric Name
    29485-8026EXCEDRIN EXTRA STRENGTH PAIN RELIEVERACETAMINOPHEN, ASPIRIN, and CAFFEINE
    29485-8027EXCEDRIN EXTRA STRENGTH PAIN RELIEVERACETAMINOPHEN, ASPIRIN, and CAFFEINE
    0067-2000ExcedrinAcetaminophen, Aspirin (NSAID), and Caffeine
    0067-2001ExcedrinAcetaminophen, Aspirin (NSAID), and Caffeine
    0067-8202ExcedrinAcetaminophen, Aspirin (NSAID), and Caffeine
    0067-8203ExcedrinAcetaminophen, Aspirin (NSAID), and Caffeine
    53808-0834ExcedrinAcetaminophen, Aspirin (NSAID), and Caffeine
    70518-3399ExcedrinAcetaminophen, Aspirin (NSAID), and Caffeine
    52904-868Excedrin Extra Strengthacetaminophen, aspirin (nsaid), and caffeine
    0067-8151Excedrin Extra Strength and Excedrin Tension HeadacheAcetaminophen, Aspirin (NSAID), and Caffeine

    Trademark Results [Excedrin]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    EXCEDRIN
    EXCEDRIN
    98594008 not registered Live/Pending
    Haleon CH SARL
    2024-06-10
    EXCEDRIN
    EXCEDRIN
    97425413 not registered Live/Pending
    GSK Consumer Healthcare SARL
    2022-05-24
    EXCEDRIN
    EXCEDRIN
    97210682 not registered Live/Pending
    GSK Consumer Healthcare SARL
    2022-01-10
    EXCEDRIN
    EXCEDRIN
    97210676 not registered Live/Pending
    GSK Consumer Healthcare SARL
    2022-01-10
    EXCEDRIN
    EXCEDRIN
    86434099 4978864 Live/Registered
    GSK CONSUMER HEALTHCARE S.A.
    2014-10-24
    EXCEDRIN
    EXCEDRIN
    85243455 3985911 Live/Registered
    GSK CONSUMER HEALTHCARE S.A.
    2011-02-16
    EXCEDRIN
    EXCEDRIN
    74504161 1892912 Dead/Cancelled
    Bristol-Myers Squibb Company
    1994-03-23
    EXCEDRIN
    EXCEDRIN
    73661685 1472811 Dead/Cancelled
    BRISTOL-MYERS COMPANY
    1987-05-18
    EXCEDRIN
    EXCEDRIN
    72080162 0696323 Dead/Cancelled
    BRISTOL-MYERS COMPANY
    1959-08-25

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.